Axa S.A. Biogen Inc. Transaction History

Axa S.A.

  • $199 Billion
  • Q3 2025

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$113.38 - $135.49 $5.15 Million - $6.15 Million
-45,397 Reduced 29.48%
108,572 $13.6 Million
Q1 2025

May 15, 2025
SELL
$133.43 - $153.27 $1.02 Million - $1.18 Million
-7,667 Reduced 4.74%
153,969 $21.1 Million
Q4 2024

Feb 14, 2025
BUY
$146.47 - $191.55 $15.2 Million - $19.9 Million
103,677 Added 178.88%
161,636 $24.7 Million
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $2.66 Million - $3.33 Million
-14,043 Reduced 19.5%
57,959 $11.2 Million
Q2 2024

Feb 25, 2025
SELL
$190.52 - $236.72 $17.1 Million - $21.2 Million
-89,634 Reduced 55.45%
72,002 $16.7 Million
Q2 2024

Aug 14, 2024
SELL
$190.52 - $236.72 $64 Million - $79.5 Million
-335,836 Reduced 82.35%
72,002 $16.7 Million
Q1 2024

May 15, 2024
SELL
$212.02 - $267.71 $9.1 Million - $11.5 Million
-42,905 Reduced 9.52%
407,838 $87.9 Million
Q4 2023

Jul 16, 2024
BUY
$222.59 - $267.94 $9.55 Million - $11.5 Million
42,905 Added 10.52%
450,743 $117 Million
Q4 2023

Feb 14, 2024
BUY
$222.59 - $267.94 $2.11 Million - $2.54 Million
9,494 Added 2.15%
450,743 $117 Million
Q3 2023

Nov 14, 2023
BUY
$253.3 - $285.89 $265,205 - $299,326
1,047 Added 0.24%
441,249 $113 Million
Q2 2023

Aug 14, 2023
BUY
$275.25 - $318.06 $6.66 Million - $7.7 Million
24,198 Added 5.82%
440,202 $125 Million
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $7.52 Million - $8.57 Million
29,308 Added 7.58%
416,004 $116 Million
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $34.6 Million - $42 Million
136,991 Added 54.86%
386,696 $107 Million
Q3 2022

Feb 14, 2023
BUY
$194.69 - $268.46 $7.02 Million - $9.68 Million
36,058 Added 16.88%
249,705 $66.7 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $7.02 Million - $9.68 Million
36,058 Added 16.88%
249,705 $66.7 Million
Q2 2022

Feb 14, 2023
BUY
$187.54 - $223.02 $1.93 Million - $2.3 Million
10,292 Added 5.06%
213,647 $43.6 Million
Q2 2022

Aug 15, 2022
BUY
$187.54 - $223.02 $1.93 Million - $2.3 Million
10,292 Added 5.06%
213,647 $43.6 Million
Q1 2022

Feb 14, 2023
SELL
$193.77 - $244.14 $8.98 Million - $11.3 Million
-46,350 Reduced 18.56%
203,355 $42.8 Million
Q1 2022

May 13, 2022
SELL
$193.77 - $244.14 $3.53 Million - $4.44 Million
-18,198 Reduced 8.21%
203,355 $42.8 Million
Q4 2021

Feb 14, 2022
BUY
$223.92 - $287.77 $2.66 Million - $3.41 Million
11,866 Added 5.66%
221,553 $53.2 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $4.46 Million - $5.81 Million
15,754 Added 8.12%
209,687 $59.3 Million
Q2 2021

Aug 13, 2021
BUY
$259.0 - $414.71 $6.23 Million - $9.97 Million
24,043 Added 14.15%
193,933 $67.2 Million
Q1 2021

May 14, 2021
BUY
$242.95 - $284.63 $5.62 Million - $6.59 Million
23,137 Added 15.77%
169,890 $47.5 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $9.41 Million - $14.2 Million
-39,814 Reduced 21.34%
146,753 $35.9 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $17.9 Million - $20.7 Million
-67,621 Reduced 26.6%
186,567 $52.9 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $17.8 Million - $23.6 Million
68,828 Added 37.13%
254,188 $68 Million
Q1 2020

May 15, 2020
BUY
$268.85 - $341.04 $1,344 - $1,705
5 Added 0.0%
185,360 $58.6 Million
Q4 2019

Feb 18, 2020
BUY
$220.06 - $304.07 $4.69 Million - $6.48 Million
21,326 Added 13.0%
185,355 $55 Million
Q3 2019

Nov 14, 2019
SELL
$217.44 - $243.88 $6.63 Million - $7.43 Million
-30,483 Reduced 15.67%
164,029 $38.2 Million
Q2 2019

Aug 13, 2019
SELL
$219.29 - $241.72 $5.83 Million - $6.43 Million
-26,592 Reduced 12.03%
194,512 $45.5 Million
Q1 2019

May 14, 2019
SELL
$216.71 - $338.96 $28.1 Million - $44 Million
-129,765 Reduced 36.98%
221,104 $52.3 Million
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $9.91 Million - $12.6 Million
-35,598 Reduced 9.21%
350,869 $106 Million
Q3 2018

Nov 08, 2018
BUY
$293.51 - $383.83 $549,744 - $718,913
1,873 Added 0.49%
386,467 $137 Million
Q2 2018

Aug 13, 2018
BUY
$257.52 - $306.91 $283,014 - $337,294
1,099 Added 0.29%
384,594 $112 Million
Q1 2018

May 14, 2018
BUY
$260.13 - $367.91 $595,437 - $842,145
2,289 Added 0.6%
383,495 $105 Million
Q4 2017

Feb 13, 2018
SELL
$307.64 - $344.58 $12.3 Million - $13.8 Million
-40,016 Reduced 9.5%
381,206 $121 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $118 Million - $139 Million
421,222
421,222 $132 Million

Others Institutions Holding BIIB

# of Institutions
1,077
Shares Held
131M
Call Options Held
3.77M
Put Options Held
2.31M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email